Phenytoin dosage adjustment in Saudi epileptics: Utilization of steady-state pharmacokinetic parameters

European Journal of Neurology

Volumn 6, Issue 3, 1999, Pages 331-334

  Abduljabbar, Mohammed ^a   Al Khamis, Khalil ^b   Ogunniyi, Adesola ^a   Daif, Abdul Kader ^a   Al Yamani, Mohammed ^b  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antiepileptic drugs; Epilepsy; Pharmacokinetics; Phenytoin; Seizures

Indexed keywords

PHENYTOIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY WEIGHT; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE CALCULATION; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; SAUDI ARABIA; TONIC CLONIC SEIZURE;

EID: 0033047495     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.630331.x     Document Type: Article

References (12)

1. Al-Khamis KIM (1995). Determination of phenobarbital, phenytoin and carbamazepine in human serum: comparison of fluorescence polarization immunoassay with high performance liquid chromatography. Saudi Pharmaceutical J 3:95-103.
2. Andoh B, Idle JR, Sloan TP, Smith RL, Woolhouse N (1980). Inter-ethnic and inter-phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin. Brit J Clin Pharmacol 9:282-283.
3. Bauer LA, Blouin RA (1983). Phenytoin Michaelis-Menten pharmacokinetics in Caucasian pediatric patients. Clin Pharmacokinet 8:545-549.
4. Benet LZ, Mitchell JR, Sheiner LB (1990). Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: The Pharmacological Basis of Therapeutics (editors) Goodman AG, Rail TW, Nies AS, Taylor P. New York, McGraw Hill. pp. 3-32.
5. Brodie MJ, Dichter MA (1996). Antiepileptic Drugs. New Eng J Med 334:168-175.
6. Chiha K, Ishizaki T, Miura H, Minagawa K (1980). Michaclis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient. J Pediatr 96:479-484.
7. Dollery C (1991). Phenytoin sodium. In: Therapeutic Drugs. Edinburgh, Churchill Livingstone. pp. 93-98.
8. Eadie MJ (1984). Anticonvulsant drugs: an update. Drugs 27:328-363.
9. El-Sayed YM, Islam SI (1989). Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients. Int J Clin Pharmacol Therap Toxicol 27:173-178.
10. Lee HS, Chan KY (1981). Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore. Therap Drug Monitor 3:247-552.
11. Ludden JM, Allen JP, Valutsky WA, Vicuna AV, Nappi JM, Hoffman SF, et al. (1977) Individualization of phenytoin dosage regimens. Clin Pharmacol Therap 21:287-293.
12. Rall TW, Schleifer LS (1990). Drugs effective in the therapy of the epilepsies. In: The Pharmacological Basis of Therapeutics (editors) Goodman AG, Rall TW, Nies AS, Taylor P. New York, McGraw Hill. pp. 436-462.